Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Carcinoma to the Uterine Cervix”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)WithdrawnNCT00057928
What this trial is testing

S0227 Cisplatin With Either Paclitaxel or Gemcitabine in Recurrent, Persistent, or Metastatic Cervical Cancer

Who this might be right for
Cervical Cancer
SWOG Cancer Research Network
Testing effectiveness (Phase 2)Looking for participantsNCT06157151
What this trial is testing

PRGN-2009 in Combination With Pembrolizumab in Patients With Recurrent or Metastatic Cervical Cancer

Who this might be right for
Cervical CancerHPV-Related CarcinomaHPV-Related Malignancy+2 more
Precigen, Inc 24
Testing effectiveness (Phase 2)WithdrawnNCT05998941
What this trial is testing

A Trial of TQB2868 Plus Platinum-based Chemotherapy With or Without Bevacizumab in the First-line Treatment of Persistent, Recurrent, or Metastatic Cervical Cancer

Who this might be right for
Cervical Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Not applicableLooking for participantsNCT07400809
What this trial is testing

Cervical Cancer Oligo States (Recurrence, Metastasis) Multicentre Outcomes Study.

Who this might be right for
ChemotherapyTreatment ComplianceRadiotherapy+4 more
Tata Memorial Hospital 350
Testing effectiveness (Phase 2)Study completedNCT05021237
What this trial is testing

Personalized Ultra-fractionated Stereotactic Adaptive Radiotherapy for Metastatic Cervical Cancer

Who this might be right for
Stage IV Cervical Cancer FIGO 2018Adenosquamous Carcinoma of CervixCervical Cancer+1 more
University of Texas Southwestern Medical Center 12
Early research (Phase 1)Looking for participantsNCT06010875
What this trial is testing

A Clinical Research About CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors

Who this might be right for
Renal Cell CarcinomaOvarian CancerCervix Cancer+2 more
Chongqing Precision Biotech Co., Ltd 48
Testing effectiveness (Phase 2)Study completedNCT03816553
What this trial is testing

SHR-1210 in Combination With Apatinib in Patients With Metastatic, Persistent, or Recurrent Cervical Cancer

Who this might be right for
Recurrent Cervical CarcinomaMetastatic Cervical Cancer
Sun Yat-sen University 45
Testing effectiveness (Phase 2)Study completedNCT00430781
What this trial is testing

Pazopanib Plus Lapatinib Compared to Lapatinib Alone and Pazopanib Alone In Subjects With Metastatic Cervical Cancer

Who this might be right for
Neoplasms, Uterine CervixMetastatic Cervical Cancer
GlaxoSmithKline 228
Testing effectiveness (Phase 2)UnknownNCT05444374
What this trial is testing

A Phase II Study of Serplulimab Plus Bevacizumab in Combination With Chemotherapy in 1L Treatment of Untreated Recurrent or Metastatic Cervical Cancer

Who this might be right for
Cervical Cancer
Sichuan Cancer Hospital and Research Institute 48
Not applicableEnded earlyNCT00978874
What this trial is testing

Fluorine F 18 EF5 PET/CT Imaging in Patients With Locally Advanced or Recurrent/Metastatic Cervical Cancer

Who this might be right for
Cervical Cancer
Abramson Cancer Center at Penn Medicine 15
Testing effectiveness (Phase 2)Study completedNCT00416455
What this trial is testing

Fludeoxyglucose (FDG) F 18 PET Scan, CT Scan, and Ferumoxtran-10 MRI Scan Before Chemotherapy and Radiation Therapy in Finding Lymph Node Metastasis in Patients With Locally Advanced Cervical Cancer or High-Risk Endometrial Cancer

Who this might be right for
Cervical AdenocarcinomaCervical Adenosquamous Cell CarcinomaCervical Small Cell Carcinoma+11 more
National Cancer Institute (NCI) 384
Large-scale testing (Phase 3)Study completedNCT03635567
What this trial is testing

Efficacy and Safety Study of First-line Treatment With Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Women With Persistent, Recurrent, or Metastatic Cervical Cancer (MK-3475-826/KEYNOTE-826)

Who this might be right for
Cervical Cancer
Merck Sharp & Dohme LLC 617
Large-scale testing (Phase 3)Looking for participantsNCT05798819
What this trial is testing

GLS-010 Plus Platinum-containing Chemotherapy±Bevacizumab as First-line Treatment for Persistent, Recurrent, or Metastatic Cervical Cancer

Who this might be right for
Persistent, Recurrent, or Metastatic Cervical Cancer
Guangzhou Gloria Biosciences Co., Ltd. 424
Large-scale testing (Phase 3)Not Yet RecruitingNCT07177716
What this trial is testing

Efficacy and Safety of LB1410 Plus Lenvatinib With or Without LB4330 in Advanced Recurrent/Metastatic Cervical Cancer

Who this might be right for
Cervical Cancer
L & L Bio Co., Ltd., Ningbo, China 120
Testing effectiveness (Phase 2)Ended earlyNCT04230954
What this trial is testing

Cabozantinib Plus Pembrolizumab for Recurrent, Persistent and/or Metastatic Cervical Cancer

Who this might be right for
Cervical CancerRecurrent Cervical CancerMetastatic Cervical Cancer+1 more
University of South Alabama 5
Testing effectiveness (Phase 2)Looking for participantsNCT06241781
What this trial is testing

Autologous Tumor Infiltrating Lymphocytes (GT101 Injection) in Patients With Recurrent or Metastatic Cervical Cancer

Who this might be right for
Adult
Grit Biotechnology 83
Testing effectiveness (Phase 2)WithdrawnNCT06099418
What this trial is testing

Efficacy and Safety of VB10.16 Alone or in Combination With Atezolizumab in Patients With Advanced Cervical Cancer.

Who this might be right for
HPV-Related Cervical CarcinomaHPV-Related MalignancyCervical Cancer
Nykode Therapeutics ASA
Early research (Phase 1)UnknownNCT03676959
What this trial is testing

A Clinical Study of PD-L1 Antibody ZKAB001（Drug Code） in Recurrent or Metastatic Cervical Cancer

Who this might be right for
Cervical Cancer
Lee's Pharmaceutical Limited 101
Testing effectiveness (Phase 2)Looking for participantsNCT06155396
What this trial is testing

RC48-ADC Combination With Zimberelimab Injection Therapies at Least First-line Platinum-containing Standard Therapy Failed With Recurrent or Metastatic Cervical Cancer

Who this might be right for
Cervical Cancer
RemeGen Co., Ltd. 116
Testing effectiveness (Phase 2)Study completedNCT02001623
What this trial is testing

Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors

Who this might be right for
Ovary CancerCervix CancerEndometrium Cancer+5 more
Seagen Inc. 195
Next Page